The radial artery for coronary artery bypass grafting by Nežić, D. et al.
Coronary artery bypass grafting (CABG) is the
standard surgical procedure for the treatment of
advanced coronary artery disease. CABG surgery
has been demonstrated to improve symptoms and,
in specific subgroups of patients, to prolong life.
Despite its success, the long-term outcome of coro-
nary bypass surgery is strongly influenced by the
fate of the vascular conduits used. Previous long-term
studies have shown unsatisfactory patency of saphe-
nous vein grafts used for myocardial revascularisation,
compared with internal mammary artery grafts. Re-
cently, the use of radial artery for CABG has enjoyed
a revival, on the basis of the belief that it will help im-
proving long-term results of coronary operations. The
recent reports of encouraging mid-term and long-term
patency rates of the radial artery, supports its contin-
ued use as a bypass conduit. In this paper, we review
the current knowledge about the radial artery as a by-
pass graft, with special emphasis on the clinical results.
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INTRODUCTION
The clinical and prognostic benefits of coronary arterybypass grafting (CABG) for some subgroups of pa-
tients with ischemic heart disease are well accepted,
and worldwide every year almost 1 million patients un-
dergo coronary revascularisation.1 CABG provides ex-
cellent short and intermediate-term results, but long-term
outcome is  strongly influenced by the fate of the vascular
conduits used.
Ten years after CABG, 90% of internal thoracic artery
(ITA) grafts are patent and disease free while 75% of sa-
phenous vein grafts (Svg) are occluded or severely ste-
nosed.2 Within the first month after coronary bypass sur-
gery venous grafts may occlude due to thrombosis and/or
technical failure. Between 1 month and 1 year after opera-
tion, intimal hyperplasia takes place in still open graft.
Thereafter, the development of atherosclerosis in the vein
grafts starts which accelerates after the fifth post-operative
year.3,4 The attrition rate of venous grafts is highest, 8%
to 12% within the first 4 weeks after CABG. By the end
of the first year, 12% to 20% of the saphenous vein grafts
have been occluded. In the following 4 years the attrition
rate is low (1% to 2% per year), but thereafter graft clo-
sure is 2 times more frequent. By 10 years postoperatively
about 50% of the venous grafts have closed, and 25%
have been severely stenosed.3,4  
Impressive long-term patency of the LITA-LAD (left
anterior descending coronary artery) graft, coupled with
proven long-term survival benefit, has led to its becoming
a "golden standard" of CABG. Multiple groups have re-
ported significantly better CABG survival when both ITA
conduits are used concomitantly compared with a single
ITA.1,5,6  Death, reoperation and percutaneous translumi-
nal coronary angioplasty were significantly more frequent
for patients undergoing single rather than bilateral ITA
grafting. 
Thus, the use of arterial conduits has expanded beyond
the ITAs to include the right gastroepiploic artery, the in-
ferior epigastric artery and the radial artery. The assump-
tion is that although the performance of one or two arterial
ITA graft is good, more arterial grafts should perform bet-
ter. 
Several studies have documented excellent clinical re-
sults and satisfactory short and mid-term patency rates at
restudy angiography of radial artery conduits used for
CABG.7.8.9.   One long-term angiographic study has dem-
onstrated disease-free patency rate of the radial artery
graft of  88%, nine years after surgery,10 promoting radial
artery conduit as second or third arterial graft of choice in
coronary revascularisation.   
HISTORICAL  NOTE
Carpentier and colleagues11 first introduced the radial
artery (RA) for myocardial revascularisation in 1971. Un-
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fortunately, high occlusion rates were reported and the
utilisation of the RA was almost completely abandoned.
Early graft failures were attributed to graft vasospasm and
premature occlusions to intimal hyperplasia, likely the re-
sult of endothelial denudation from mechanical dilatation
and trauma of technically imperfect skeletonized harvest-
ing. In 1992, Acar and colleagues12 strongly recom-
mended the use of RA having detected several patent RA
grafts up to 18 years after the initial myocardial revascu-
larisation and due to excellent early patency of RA
(100%, 56 patients) in their sample. Encouraging early
and mid-term patency rates were obtain during this revival
of radial artery conduit, and were ascribed to an improved
harvesting technique, together with the use of calcium
channel blockers or other vasodilators to prevent periop-
erative spasm of the graft. These reports led many other
groups to reassess the role of this conduit in coronary by-
pass procedures.  
ADVANTAGES OF THE RADIAL ARTERY CONDUIT
Several anatomopathological features present the radial
artery conduit as an excellent graft to be used in coronary
revascularisation:
a) it is easy to harvest it parallel with the ITA;
A standard incision (nondominant arm) over the RA is
used to facilitate harvesting from its origin in the proximal
forearm (3 cm distal to the elbow crease, lateral to the bi-
ceps tendon) to 1 cm before the proximal crease at the
wrist level, centred over the radial pulsation, between the
flexor carpi radialis and the radial tubercle. After incision
of the skin, low-current diathermy is used for the subcuta-
neous tissue and deep fascia in the proximal third of the
forearm (the RA is well away from the fascia). The deep
fascia in the distal forearm is incised with scissors to
avoid thermal injury as the artery became more superfi-
cial. A self-retaining retractor is used to separate the bra-
hioradialis and flexor carpi muscles, and a silicone elas-
tomer vessel loop is placed around the radial artery pedi-
cle (including the radial artery venous comitantes) to fa-
cilitate handling, mobilisation and dissection of the pedi-
cle (Figure 1.). The branches of the RA are divided be-
tween small clips using scissors. In the patients undergo-
ing ultrasonic dissection of the RA pedicle, the sharp-
pointed hook blade (moderate intensity, the variable
mode) is used. Branches that bled during or after transec-
tion are controlled with small clips. Care is also taken to
avoid damaging the lateral antebrachial cutaneous (sen-
sory) nerve (it lies at the level of the fascia enveloping the
brachioradialis muscle at its volar border and supplies the
skin of the radial aspect and adjacent dorsal surface of the
forearm), as well as the superficial radial (sensory) nerve.
It travels beneath the brachioradialis muscle and parallel
to the RA in its proximal and middle third, supplying the
dorsal skin of the thumb13,14.
b) it is long enough to be used as a conduit to any coro-
nary territory;
The average RA length suitable for bypass and capable
to reach any coronary artery territories, varies between 18
and 22 cm.15 Harvested in skeletonized fashion, RA ap-
peared to be even longer than harvested as the pedicled
graft16. Radial artery graft is free from internal valves (un-
like saphenous vein graft), so bi-directional blood flow is
possible and RA can be used so as to create an ’’anasto-
motic network’’ between the coronary artery territories.
The ends of the RA are anastomosed in an end-to-side
fashion to different coronary arteries. Then the RA is at-
tached in a side-to-side fashion to the LITA,17 or to the
ascending aorta (a Cabrol-type-proximal anastomosis
technique),18 thus forming the anastomotic network.
Figure 1.
RADIAL ARTERY HARVESTING (a - SELF-RETAINING
RETRACTOR , b - SILICONE ELASTOMER VESSEL
LOOP, /RADIAL ARTERY - WHITE ARROWS)
Figure 2. 
DOPPLER ULTRASONOGRAPHY OF THE RADIAL AR-
TERY (RADIAL ARTERY DIAMETER - WHITE STARS)
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c)  it is adapted to higher arterial pressures and large
enough in calibre to match the most of the coronary arter-
ies; 
d) it is easy to handle due to its thick muscular wall; 
The RA is a thick-walled muscular artery (type III ar-
tery due to He’s classification19  of arterial grafts accord-
ing to their physiologic and embryologic properties) and
its inner diameter varies between 2  to 3 mm.14,15   The in-
tima has one layer of endothelial cells beneath, where
multiple layers of subendothelial  cells, and small amount
of myocytes, are present. The internal elastic lamina has
multiple fenestrations, and the media is constituted by
many leiomyocytes, elastic and collagen fibres, fibroblasts
and rare macrophages. The external lamina is less individ-
ualised than the internal lamina. Some evidence suggests
that the vasa vasorum, nerves and lymphatic vessels are
confident to the adventitia, while others describe vasa va-
sorum penetration into RA media (superficial layers)15. 
e) it can be harvested in a majority of patients (obesity,
diabetes mellitus, chest wall and mediastinal radiation or
previous laparotomy do not apply to radial artery harvest-
ing).
POTENTIAL DISADVANTAGES OF THE RADIAL AR-
TERY CONDUIT
Removal of the radial artery poses the risk of ischemic
complications to the hand, particularly the thumb and in-
dex finger, which could be deprived of flow in individuals
with anatomic arterial variations that do not allow ade-
quate collateral flow across the palm. The anatomic fea-
ture that permits harvesting of RA is the presence of anas-
tomoses across the hand between the radial and ulnar ar-
teries, in the form of several arches. The most important
pathway is the superficial palmar arch, which typically
originates from the ulnar artery and provides the majority
of arterial supply to the digits. If the superficial palmar
arch is intact, than collateral flow to the radial aspect of
the hand should be adequate if the RA is removed. How-
ever, there are several anatomic variants that may lead to
hand ischemia with RA harvesting. These include an in-
complete superficial palmar arch, RA dominance of the
superficial palmar arch and absence or malformation of
the ulnar artery. The frequency of an incomplete superfi-
cial palmar arch is reported to range from 6% to 34%20.
Although additional data about collateral circulation, ul-
nar or radial artery agenesis can be detected using the
Doppler ultrasound (Fig. 2.), angiographic examination is
still the gold standard21.  Thus, before harvesting the RA
it is mandatory to assess the adequacy of the ulnar collat-
eral circulation to the hand. Methods to detect adequate
forearm collateral flow include the clinical modified Allen
test, pulse oximetry, digital blood pressure measurement,
flow measurement with photoplethysmography, segmen-
tal pressure measurements, laser Doppler flowmetry, mo-
dified Allen test with Doppler ultrasonography and color
Doppler with pulsed wave spectral trace of flow.14,20,22
At present, most studies have examined the Allen test or
a variation on this test as an index of the immediate safety
for harvesting the RA.
Using clinically modified Allen’s test the ulnar and ra-
dial arteries are compressed at the wrist for  >  30 seconds
(s) to induce hand ischemia. Blood is evacuated from the
hand by clenching. The ulnar artery is released and if hy-
peraemic reperfusion at the tips of the thumb and index
fingers occurs < 5 s, then the test is called "normal" and
the RA harvested. If reperfusion occurs after 6-10 s, then
the test is called "equivocal" and mostly the RA is used.
But if the reperfusion occurs   >10 s, then the test is
deemed "abnormal" and the RA is not used.23
Using pulse oximetry a pulse oximeter sensor is placed
on the thumb of the planned donor extremity (usually
nondominant arm). If the oxygen saturation exceeds 90%,
both ulnar and radial arteries are compressed at the wrist
TABLE 1
MID-TERM RADIAL ARTERY CONDUIT ANGIOGRAPHIC PATENCY
Authors Study design
% of pts
reassessed
Angiographic patency Years to
reangiogramRa Svg Rita
Bhan 1999 retrospective 21.6 (62/287) 96.8% (60/62) 1.4+0.4
Iaco 2001 retrospective 43.9(72/164) 95.6%(87/91)* 88.8%(8/9) 4.0+2.3
Calafiore
2002
retrospective 19.8(57/288) 99.0%(100/101)* 91.7%(11/12) 100%(5/5) 2.9+2.3
Khot 2004 retrospective ?(310/?) 53.1%(204/398)* 64.0%(174/272) 79.2%(61/77) 1.6+1.4
Zachariax
2004
retrospective,
propensity sc.
20.5(190/925) 68.2%(165/242)* 63/3%(372/588) 1.8+1.4
Shah 2005 retrospective 4.5(219/4872) 90.6%(329/363)* 88.9%(40/45) 94.4%(51/54) 3.0+2.0
Desai 2004
prospective,
randomized
78.4(440/581
perfect p 91/8% perfect p. 86.5%
0.9+0.4
siring sign 7.0% siring sign 0.9%
* number of anastomosis reassessed
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until the oxymetric signal is lost. If release of the distal ul-
nar flow results in a return of the pulse oximeter signal to
the base line value within 10 seconds, collateral flow is
deemed adequate for radial artery usage.24 
Concerns with the adequacy of forearm collateral circu-
lation, raised by the preoperative testing method, have ex-
cluded RA harvest unilaterally in range from 5 % to 11.6
%, and bilaterally in range from 5 % to 6.4 % of patients
who are candidates for RA harvest.15 
If there are no other contraindications before harvesting
(RA plaque on ultrasound, damaged RA due to trauma of
previous canullations, the presence of an arterio-venous
fistula for haemodialysis, vasculitis, carpal tunnel syndro-
mas or Raynaud’s disease), removal of the RA does not
results in any symptoms of hand ischemia or motor dys-
function. Some studies21,22   have confirmed enhanced
flow in the remaining artery to the forearm (immediately
after RA was harvested) with no acute dilatation of that
artery. Mid-term as well as long-term follow-up studies
(few to 36 months)21,22,25,26  have demonstrated chronic
enlargement of the remaining artery (ulnar artery22  or
rather interosseous artery21) or a statistically significant
increase of mean peak systolic flow velocity in ulnar ar-
tery (compared with the preoperative value)26, to compen-
sate blood supply of the forearm. 
Although acute hand ischemia with serious motor defi-
ciency (requiring surgical reintervention), was reported in
two articles, de facto the same case report (coming from
the same hospital, presenting the same patient with identi-
cal angiographic material) was published twice, presented
by different authors.27,28  In that single case angiographic
examination confirmed ulnar artery agenesis, although pe-
rioperative tests established that there was good perfusion
to the hand via the collateral vessels. Circulation was re-
stored by performing brachioradial bypass grafting using
reversed cephalic vein.27,28 
The most common complications noted, occurring in
2.6% to 15.2% of patients,13,22,24  are sensory abnormali-
ties, especially cutaneous paresthesis and/or numbness in
the radial distribution of sensory nerves (lateral ante-
brachial cutaneous nerve, superficial branch of the radial
nerve) due to nerve injury from direct trauma, oedema or
carpal tunnel haematoma. Long-term persistence of the
symptoms (4.2 + 2.1 years postoperatively)13,24  were re-
corded in 10% of the patients, but were considered a "con-
stant and significant source of discomfort" in only 1% of
patients. Fortunately, most patients tolerated sensory loss
and subjective thumb weakness without a significant limi-
tation in hand activities.
Patients who had undergone endoscopic RA harvesting
have been reported to have significantly fewer major
complications (haematomas, wound infections, neural-
gias) than patients who underwent the open RA harvesting
technique.29,30  The integrity of the conduit has not been
altered, as demonstrated by the histological findings of the
conduit. Although the technique is appealing, the long
term patency rates of endoscopically harvested RA have
yet to be reported.
In patients with coronary artery disease, RA atheros-
clerotic involvement is more frequent (up to 6.9
%)31,32,33 than that of the gold standard ITA. Factors asso-
ciated with an increased likelihood of medial calcification
and atherosclerosis included a history of smoking, diabe-
tes, hypercholesterolemia, peripheral artery disease and
chronic renal failure (p < 0.05).32  The RA that is heavily
calcified poses technical difficulties intraoperatively apart
from indicating a doubtful long-term patency. However,
Gaudino and colleagues33  have reported that the early
atherosclerotic signs, observed very often in RA using
subtle histopathological or echographic methods do not
seem to have the potential to influence midterm RA graft
patency (93.3 % at a mean interval of  61 +  7 months)
and endothelial function.
TABLE 2
LONG-TERM RADIAL ARTERY CONDUIT ANGIOGRAPHIC PATENCY
Authors Study design
% of pts
reassessed
Angiografphic patency Years to
reangiogramRa Svg Rita
Acar 1998 retrospective 5.5(50/910) 82.8%(53/64)* 5.6+1.1
Possati 1998 prospective 20.9(68/325) 88.6%(55/62) 74.0%(43/58) 75.0%(3/4) 4.9+0.5
Possati 2003 prospecitive 27.7(90/235) 90.5%(76/84) 67.1%(49/73) 85.7%(6/7) 8.8+1.0
Buxton 2003
prospective,randomi
zed II groups, Ra
vs Frita or Svg
Ra 27.9
97.4%(38/39) 100%(29/29)
5.0+1.0
Frita 20.0
Ra 32.9
87.5% (21/24) 95.5% (21/22)
Svg 27.5
Cameron
2004
retrospective 16.7(50/300) 88.7%(55/62)* 91.7%(33/36) 94.4%(17/18) 5.2+0.4
*Number of anastomosis reassessed
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The RA is expected to be more vasospastic compared to
other arterial grafts due to its characteristics of being a
type III artery and of having predominantly - adrenergic
receptors. Thus, the propensity for the RA to go into
spasm is likely due to the higher density of muscle cells in
the media of this vessel (organised into multiple tight lay-
ers compared with ITA, gastroepiploic and epigastric ar-
teries with fewer muscle cells that are less organised)34 re-
sulting in a significantly higher maximal contractile force
in response to vasoconstricting agents. Those agents in-
clude norepinephrine, serotonin, endothelin I and angi-
otensin II generated in response to endothelial damage
and dysfunction due to inflammatory response to cardio-
pulmonary bypass or surgical stress, as well as exo-
genously administered inotropes or vasoconstrictors.15,35  
He and Yang36  have suggested that the RA propensity to-
ward spasm is not solely a function of the muscular wall
but that an enhanced  reactivity to afore-mentioned va-
soactive mediators is of  key importance. Vasospasm has
been reported  in 4% to 10% of all RA grafts.35 
It is commonly agreed upon that RA harvest must be
performed with gentle mobilisation of the RA, with light
tractions, minimal touch and minimal diathermy or ultra-
sonic dissection, thus diminishing endothelial trauma re-
lated to harvesting process. Currently, the propensity of
the RA to spasm has greatly been reduced using topically
different categories of vasodilators, including calcium
channel blockers, the phosphodiesterase (papaverin-short
acting, and milrinone-long acting)35  inhibitors, -adrener-
gic antagonists (i.e. phenoxybenzamin)37 as well as drug
mixtures such as verapamil and nitroglycerin (VNG) or
verapamil and papaverine.14, 15  Clinically useful agents
should ideally be effective against a wide variety of endo
and egzogenously delivered substances causing receptor-
mediated as well as receptor-independent vasoconstriction
of the RA graft.37 Furthermore, antispasmodic activity
should be maintained throughout the immediate postop-
erative period. Currently, no single topical antispasmodic
agent fulfils all the criteria necessary to prevent RA vaso-
spasm in clinical practice. VNG solution is effective
against a broad range of vasoconstricting agents, but its
relatively short duration of effects (up to 5 hours)37  limits
its usefulness in the clinical practice. Phenoxybenzamin is
a more effective agent to prevent - adrenergic spasm, but
has little effect on vasoconstriction caused by noncatecho-
lamine vasoactive mediators. Its prolonged duration of ac-
tion (up to 18 hours in vitro)35  as well as the ability to
prevent catecholamine mediated vasoconstriction,37 rec-
ommends it as a useful agent in the immediate postopera-
tive period, especially in CABG patients requiring inot-
ropic support (dopamine, epinephrine, norepinephrine).
Finally, a combination of agents may be appropriate to
combat vasospasm of the RA graft and thereby reduce the
likelihood of early graft failure. It has recently been
shown that adenoviral-mediated gene transfer (suggesting
a possible future clinical application), causing overex-
presion of nitric oxide synthase in human RA, can mini-
mise RA vasospasm through the inhibition of voltage-de-
pendent as well as receptor-dependent pathways.38
In order to prevent delayed vasospasm, oral calcium
channel antagonists have been recommended for as long
as 1 year after surgery for patients receiving RA conduits.
In a prospective, randomised study, Gaudino and col-
leagues39 have confirmed (a 5-year angiographic control
study)  that continuation of diltiazem beyond 1 year (in
patients with RA conduit) provided no additional benefit
in terms of clinical and angiographic outcomes. The long-
term (109+9 months) angiographic results of the same co-
hort of patients have presented no difference in angiog-
raphic patency of the RA conduits  between those patients
who continued versus those who suspended calcium chan-
nel blocker therapy.10  Furthermore, the same authors
have recently presented prospective, randomised study,
confirming that calcium channel blocking therapy started
immediately after surgery and continued for the first post-
operative year did not affect either radial artery conduit
patency or clinical outcomes. However, the role of cal-
cium channel blocking therapy in the early postoperative
period, when radial artery tendency to spasm is thought to
be maximal, has yet to be clarified, and its use remains
routine in many centres.
OPTIMAL  GRAFTING  STRATEGY
Optimal placement of the radial artery to achieve satis-
factory long-term patency has yet to be clarified. 
There is accumulating evidence that grafting the RA to
coronary targets with moderate stenoses (<70 %) results
in statistically significantly reduced conduit
patency.41,42,43,44 Furthermore, in prospective, random-
ised study, Desai and colleagues43 have recently presented
that targeted coronary arteries with stenosis of  > 90%, as
compared with those coronary-vessel lesions with stenosis
of  70 - 89%, were associated with a lower rate of occlu-
sion of the radial artery conduit (5.9% vs. 11.8%, p =
0.03) , as well as with a lower rate of  "string sign" in ra-
dial artery grafts (3.7% vs. 12.4%, p < 0.001). The con-
cept of competitive flow suggests that graft flow is influ-
enced by native coronary flow.35 Grafted conduits may
therefore fare better in conditions of poor native coronary
flow, i.e. in the case of high-grade stenosis or occlusion of
targeted coronary arteries.
Some studies have identified target location as signifi-
cant predictor for conduit failure, thus lower angiographic
patency rates for RA grafts to both the circumflex and
right (statistically significant) coronary arteries were re-
ported.41,42 These findings remains controversial, because
there are many studies confirming that target vessel loca-
tion does not influence RA conduit patency.10.43,45 There
are few options to perform the proximal RA anastomosis.
The most commonly used are to the aorta as an aorto-
coronary conduit or to the another graft (usually ITAs) as
a composite conduit (in a T or Y fashion). It has been
speculated that the histologic and structural characteristics
of the RA can render this conduit particularly prone to
vessel wall ischemia and consequent intimal proliferation,
especially when exposed to the hemodynamic stress due
to the sharp increase in dp/dt  present in the initial part of
the ascending aorta. For this reason some authors have ad-
vocated performing the proximal anastomosis of RA
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grafts to a vascular region with a lower dp/dt, such as an
ITA graft.46 
Maniar et colleagues 42 have reported that the site of
proximal anastomosis does not appear to influence RA
conduit patency. In their study angiographic (average pe-
riod to reangiogram 26.1 months) RA conduit patency in
aortocoronary versus composite configuration demon-
strated no statistically significant difference (72.0% vs.
70.5%).  Other authors47,48,49 have reported excellent
mid-term (average period to reangiogram 16.2, 36,8 and
59 months, respectively) RA conduit patency (96.8%,
90.6% and 91.9%, respectively) in aortocoronary configu-
ration. Matchless results (patency rate of 99%) have also
been reported  for composite configuration (average pe-
riod to reangiogram 35 months).
FOLLOW - UP  STUDIES
Since the 1990s, several authors have demonstrated en-
couraging mid-term as well as long-term results of the RA
conduit in coronary artery bypass surgery.7,10,45,47  
The most essential data for mid-term studies (average
period to reangiogram up to four years) are presented in
table 1. Mid-term angiographic RA conduit patency varies
between 90.6% to 99%48,46  (excluding manuscripts pre-
sented by Khot50  and by Zacharias51) and the percentage
of grafts followed up with angiography varies from 4.5%
to 78.4%.48,43    However, these encouraging data must be
interpreted with caution. Almost all the data (excluding
manuscript by Desai43 ) are from retrospective, nonran-
domized studies, and, unfortunately, lack sufficient scien-
tific rigor to allow meaningful conclusion to be drawn, as
evidence-based medicine mandates the prospective ran-
domised trials as the most accurate tool for determing a
treatment benefit compared with a control population.52  
A note of caution has recently come from Clevelend
Clinic in a form of retrospective, symptom-directed
angiographic study on RA graft patency, presented by
Khot et colleagues.50 At average follow-up of 1.6 +1.4
years RA grafts had a patency rate of 51.3%, which was
significantly lower than that of LITA (90.3%, P<0.0001)
or saphenous vein grafts (64.0%, P=0.0016). Although
their methodology is flawed (primarily because the sam-
ple studied is composed exclusively of patients presenting
with angina), the article presents one of the largest
angiographic follow-up studies of the RA conduit patency
from a high volume Centre that has traditionally promoted
arterial grafting. The importance of the manuscript is that
it raises concerns about high RA graft failure at a time
when the RA conduit use is increasing.
Unfortunately, propensity score statistical technique53
(used to overcome most of the bias sources of non-
matched studies) was employed only in the manuscript of
Zacharias et colleagues.51  Although cumulative 0 to 6-
year survival was better for radial patients (vs patients
with Svg as second conduit), the angiographic RA con-
duits patency (1.8 + 1.4 years to reangiogram) were
68.2%, statistically not better than Svg patency rate
(63.3%). Low patency rates may stem in part from the
fact that the patency data were derived from symptomatic
patients exclusively, who reflected a worst-case scenario.
Due to possibility of silent graft occlusion, the assumption
that symptom-free patients are likely to have more patent
grafts does not justify extrapolation of better patency rates
to entire cohort. 
Neither in the article of  Shah and associates48  (average
period to reangiogram, again in symptomatic patients, 3.0
+2.0 years) the RA conduit didn’t achieve better pa-tency
rate over Svg (90.6% vs 88.9%), thus they stated "When
additional grafts are required, there is no evidence to sug-
gest that either the radial artery or saphenous vein is supe-
rior."
The well-designed prospective, randomised  trial (RAPS
- Radial Artery Patency Study) comparing the patency of
saphenous-vein grafts with that of RA grafts has recently
been reported by Desai et colleagues.43 The radial artery
was randomly assigned to bypass the major vessel in
either the right coronary territory or the circumflex terri-
tory, with the saphenous vein graft used for the opposing
territory (control). The target coronary vessels had to be at
least 1.5 mm in diameter, with proximal lesions causing
narrowing of at least 70% of the diameter. The primary
end point was graft occlusion, determined by angiography
8 to 12 months postoperatively. The angiographic study
performed one year after surgery (average period to re-
angiogram 0.9+0.4 years) in this trial demonstrated an oc-
clusion rate of 8.2% for RA conduits and 13.6% for
saphenous-vein grafts (P=0.009). However, 7% of RA
grafts (versus only 0.9% of Svg) had diffuse angiographic
narrowing (the "string sign"), resulting in a total  "bad
graft" rate of 15.2% for RA conduit (vs. 14.5% for Svg).
Perfect graft patency, defined as grafts with TIMI
(Thrombolysis In Myocardial Infarction) flow grade 3,
was similar (87.7% vs. 85.7%, P=0.37). The long-term
patency (5 to 10 years) of the RA relative to Svg grafts
will be assessed in follow-up studies. 
The most essential data for long-term studies (average
period to reangiogram  5 or more years) are presented in
table 2.
Long-term angiographic RA conduit patency varies be-
tween 82.8% to 97.4%7,8,  and the percentage of grafts
followed up with angiography varies from 5.5% to
32.9%.7,8 
In a retrospective study of  Cameron and colleagues9
(only 50 asymptomatic patients were included) the RA
graft patency was 88.7% versus 91.7% patency rate of
saphenous vein graft (average period to reangiogram 5.2
years). In addition, in a group of 21 patients who under-
went restudy coronary angiography due to recurrent an-
gina the same patency rate for the RA conduit (88%) has
been found. Therefore authors concluded that the patency
rate of 89% for RA conduit might be a true reflection of
patency rate for entire cohort. Unfortunately, authors have
overlooked the fact that average period to restudy
angiogram was only 2.7 years in symptomatic patients
(thus, in all appearance, additional graft failure can be ex-
pected in next  2.5 years). 
Excellent long-term patency rate have been reported by
Possati and colleagues in two prospective trials. In the
first one,49 the RA graft patency (≅ 5 years to re-
angiogram) have been presented to be better than saphe-
16 D. Ne‘i} et al. ACI Vol. LII
nous vein graft patency (88.6% vs. 74.0%, respectively,
P<0.4). In the second one,10 the RA conduit patency (≅9
years to reangiogram) have been established to be signifi-
cantly better than saphenous vein graft patency  (90.5%
vs. 67.1%, respectively, P<0.0001), and not worse com-
pared to ITA conduit patency (90.5% vs. 96.3%, respec-
tively, P=0.23).
The RAPCO (Radial Artery Patency and Clinical Out-
come)8  study was undertaken to compare elective angiog-
raphic patency and cardiac event-free survival of the ra-
dial artery conduit with that of the free right internal tho-
racic artery (Frita) or saphenous vein grafts during a 10-
year period after primary CABG surgery. In this prospec-
tive, randomised, single-centre trial, the RA was com-
pared with the Frita in a younger patient group, and with
Svg in an older patient group (age > 75 years). The trial
conduit was grafted to the largest available coronary ar-
tery (diameter at least 1.5 mm, proximal stenosis of at
least 70%) other than the LAD. Protocol-directed angiog-
raphy at 5 years didn’t support the hypothesis that the RA
has superior patency (RA vs. Frita – 97.4% vs. 100%: RA
vs. Svg – 87.5% vs. 95.5%) to or is associated with fewer
clinical events than free right internal thoracic artery or
saphenous vein grafts. It has to be underlined that Svg
patency appears superior to that of recorded previously,
suggesting that the choice of a large target artery and fac-
tors used to protect grafts (vasodilators and 3-hydroxy-3-
methylglutaryl coenzyme A reductase inhibitors), may
have improved the outcomes of both, the control and
study grafts.
THE FUTURE OF THE RADIAL ARTERY CONDUIT
The radial artery conduit is becoming increasingly
popular (due to excellent patency rates in some mid and
long-term studies) as a third arterial conduit in association
with LITA and RITA, or as the second in patients with
contraindications to bilateral ITA harvesting. However, it
is essential not to overlook the notes of caution coming
from some reports (i.e. Khot and Zacharias) as these re-
sults of radial artery patency are not as expected. 
The most important data are still to come. If angiog-
raphic studies between 5 and 10 years after CABG sur-
gery show that radial artery conduits are not subject to late
graft failure, they will represent an improvement over
saphenous vein conduits. If the long-term patency of ra-
dial artery conduit is shown to approach the patency rates
of right internal thoracic artery (RITA) grafts, radial ar-
tery conduit are likely to be substitute for RITA grafts as
well as for saphenous vein grafts in the future of CABG
surgery.
REZIME
Hirur{ka revaskularizacija miokarda je standardna pro-
cedura u tretmanu uznapredovale koronarne bolesti. Do-
kazano je da koronarna hirurgija uklanja simptome i
produ‘ava ‘ivot odredjenih kategorija koronarnih bolesni-
ka. Dugotrajni rezultati hirur{ke revaskularizacije mioka-
rda u velikoj meri ovise o promenama koje se vremenom
javljaju na upotrebljenom graftu. Studije dugoro~nog pra-
}enja operisanih bolesnika potvrdile su izuzetan kvalitet i
prednost grafta unutarnje torakalne arterije u odnosu na
venski graft. U skorije vreme obnovljeno je intereso-vanje
za graft radijalne arterije, sa uverenjem da }e njego-va pri-
mena omogu}iti bolje dugoro~ne rezultate. U poslednje
vreme prikazani su radovi koji potvrdjuju izu-zetnu
kratkoro~nu i dugoro~nu prohodnost grafta radijalne ar-
terije i govore u prilog  intenzivnije primene toga grafta u
hirur{koj revaskularizaciji miokarda. Na prikaz je pre-
gled sadanjih saznanja o radijalnoj arteriji kao graftu u
kardiohirurgiji, sa posebnim osvrtom na klini~ke rezultate.
Klju~ne re~i: hirur{ka revaskularizacija miokarda,
graftovi, radijalna arterija
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